Clinical Report: Insights into Neurogenetic Research Reviews

Overview

This editorial reviews contributions to the Research Topic 'Reviews in neurogenetics,' highlighting advancements in the diagnosis and treatment of neurogenetic disorders.

Background

Neurogenetic disorders encompass a range of conditions that significantly impact patient quality of life and require precise diagnostic and therapeutic strategies. The integration of genetic insights into clinical practice is essential for these complex disorders. This editorial discusses recent advancements.

Data Highlights

No numerical data available in the source material.

Key Findings

• Substantial growth in clinical trials for Charcot-Marie-Tooth disorders from 1999 to 2022, with 91% hosted in academic settings.
• Therapeutic trials constituted 86% of total trials, with a significant proportion being controlled and randomized.
• PRUNE1 syndrome is characterized by hypotonia, microcephaly, and variable cerebral abnormalities, with implications for diagnosis and prognosis.
• RNA-based therapeutics and gene therapies are emerging as leading strategies in treating neurological disorders.
• Genetic analysis of cerebrotendinous xanthomatosis revealed common variants among affected individuals, enhancing understanding of the disorder.

Clinical Implications

Clinicians should remain informed about advancements in gene therapies and their applications in treatment.

Conclusion

This editorial highlights ongoing advancements in neurogenetic research.

Related Resources & Content

1. Frontiers in Psychiatry, 2026 -- Psychiatric insights in genetic and chromosomal disorders
2. Frontiers in Ophthalmology, 2026 -- International Insights into Genetic Diagnosis and Therapeutic Approaches for Inherited Retinal Disorders
3. Frontiers in Psychiatry, 2026 -- From molecular changes to behaviour: exploring neuropsychiatric disorders
4. Brain, 2023 -- Converging cross-modal evidence for a phylogenetic age effect in neurodegenerative susceptibility
5. Alzheimer's & Dementia, 2025 -- The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders
6. PMC, 2023 -- Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence
7. PubMed, 2023 -- Practice Recommendations for Genetic Testing of Ataxias
8. The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for specialty care - Dickerson - 2025 - Alzheimer's & Dementia - Wiley Online Library
9. Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence - PMC
10. Practice Recommendations for Genetic Testing of Ataxias - PubMed